As part of its advocacy program in Europe, ACRO submits regulatory comments to European officials. This comment letter, submitted by ACRO to EMA in 2017 about Concept paper: Revision of the guideline on the role of pharmacokinetics in the development of medicinal products in the paediatric population can be found below.